Article

Alfa Chemistry Commences Supply of Clinical Standards for Chemistry Laboratory Use

Topic: Business DevelopmentPublished August 20, 2022

Legacy signals

Legacy popularity: 344 legacy views

Following varieties of certified reference materials such as environmental standards, food & beverage standards, forensic and veterinary standards, life sciences standards, petrochemical standards, and pharmaceutical and drug standards, earlier this month, Alfa Chemistry commenced the supply of clinical standards for customers worldwide to support clinical laboratory use. Chromatography is a laboratory technique to separate mixtures into single components. When conducting chromatography experiments, different analytical reagents are used depending on the various occasions. “For a clinical chemistry laboratory, ultra-pure chemical standards and reagents are appropriately prepared, handled, and ultimately used in the hope of bringing the clinical research to a new level of precision and accuracy. These chemicals are referred to as clinical standards,” said one senior scientist from Alfa Chemistry. “As for now, clinical laboratories have a diversity of clinical reagents, antibodies, and molecular probes to choose from. Overall, these certified reference materials can facilitate serum analysis, histology, hematology, cytology, and a list of other sensitive and specific assays.” The creation and subsequent production of a reagent is no easy process, which usually takes a lot of factors into consideration. At Alfa Chemistry, two clinical standards are currently provided, namely the Iopromide (CAS: 73334-07-3) and Iopanoic acid (CAS: 96-83-3). Iopromide (CAS 73334-07-3), assay by HPLC with a purity of 98.0% and higher, is an iodinated contrast medium for intravascular administration and is commonly used in X-ray imaging studies to help in performing diagnostic tests of the brain, heart, head, blood vessels or other parts of the body. Iopanoic acid (CAS 96-83-3), assay by HPLC with a purity of 95.0% and higher, is an iodine-containing radiocontrast medium. This research-grade reagent is a substrate of type 1 deiodinase and can also be used in cholecystography. As always, Alfa Chemistry is at the forefront of technical innovation, strictly follows regulatory compliance, and strives to provide the best quality chromatography reagents and standards for customers worldwide. All reference standards are subjected to rigorous quality assurance checks prior to shipment. Visit https://reagents.alfa-chemistry.com/products/clinical-standards-634.html to learn more.

Further reading

Further Reading

4 total

Article

Artificial intelligence continues to dominate business conversations, but enthusiasm alone does not guarantee results. While many companies rush to adopt AI in hopes of gaining a competitive edge, a large number of initiatives still fall short. The problem is rarely the technology itself. More often, failure happens because organizations approach AI without the structure, readiness, and discipline required for long-term success. AI projects do not fail because the technology

March 4, 2026

Article

AI Avatar Development: Real Innovation or Just Hype? In today’s hyperconnected world, attention is currency. To stand out, brands can no longer settle for flashy features or surface-level engagement. They need to build meaningful, scalable, and personalized experiences. Enter AI avatars: digital humans that are revolutionizing communication by bringing lifelike presence to virtual interactions. Imagine a team member who never takes a coffee break, speaks ten languages fluen

February 27, 2026

Article

The Quiet Engine Behind Every Connection Most people think of telecom services as towers, signals, and mobile data moving invisibly through the air. Yet behind every call that connects and every message that reaches its destination, there is another system quietly working in the background. That system is the call center. While customers often interact with telecom companies only when something goes wrong, these centers operate constantly, guiding problems toward solutions an

February 23, 2026

Article

Introduction The solar industry once believed that collecting as many leads as possible was the fastest path to growth. Marketing teams focused on filling databases with names, phone numbers, and email addresses. At first, the numbers looked promising. Dashboards showed rising interest and more inquiries than ever before. Yet behind the scenes, many companies began to notice a quiet problem. Revenue growth did not match the flood of leads. Sales teams felt overwhelmed, conver

February 6, 2026